| Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma | JCI insight |  | | 2025 | 8 | 31 |
|
| Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review | Non-coding RNA |  | | 2024 | 178 | 84 |
|
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology |  | | 2024 | 202 | 82 |
|
| Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer | Heliyon |  | | 2023 | 199 | 76 |
|
| Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells | Antioxidants |  | | 2023 | 322 | 148 |
|
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology |  | | 2023 | 249 | 129 |
|
| PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo | ACS nano |  | | 2022 | 370 | 65 |
|
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release |  | | 2022 | 400 | 443 |
|
| HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis | European Journal of Immunology |  | | 2021 | 264 | 200 |
|
| The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy | Cytokine & growth factor reviews |  | | 2021 | 278 | 204 |
|
| Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano |  | | 2021 | 404 | 564 |
|
| Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria | International Journal of Nanomedicine |  | | 2020 | 490 | 185 |
|
| Médiateurs de l'aspirine dans l'arsenal anticancéreux ? | Revue médicale suisse |  | | 2020 | 329 | 459 |
|
| Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro | ACS Nano |  | | 2019 | 458 | 596 |
|
| Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics |  | | 2019 | 594 | 787 |
|
| Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation | Biomaterials |  | | 2019 | 547 | 759 |
|
| CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes | Journal of Experimental Medicine |  | | 2019 | 499 | 421 |
|
| Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists | Pharmacological Research |  | | 2019 | 556 | 1,244 |
|
| Bionanomaterials for the Delivery of Cancer Immunotherapy | Chimia |  | | 2019 | 438 | 341 |
|
| Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle | PLOS Biology |  | | 2018 | 492 | 391 |
|
| Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics |  | | 2018 | 651 | 977 |
|
| Engineered hybrid spider silk particles as delivery system for peptide vaccines | Biomaterials |  | | 2018 | 581 | 473 |
|
| Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells | Nanomedicine |  | | 2017 | 553 | 575 |
|
| Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade | Oncoimmunology |  | | 2017 | 255 | 269 |
|
| NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response | Oncotarget |  | | 2017 | 523 | 247 |
|
| A rapid screening method to evaluate the impact of nanoparticles on macrophages | Nanoscale |  | | 2017 | 513 | 434 |
|
| Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses | Oncoimmunology |  | | 2016 | 252 | 183 |
|
| TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function | Oncoimmunology |  | | 2016 | 243 | 223 |
|
| P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model | Journal for immunotherapy of cancer |  | | 2014 | 33 | 45 |
|
| Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells | Retrovirology |  | | 2012 | 38 | 51 |
|